Rome IV Diagnostic Criteria for Functional Anorectal Pain

Apply Rome IV criteria for functional anorectal pain: five chronic proctalgia prerequisites, organic exclusion, and F2a levator ani syndrome versus F2b unspecified pain using puborectalis tenderness. Educational use only.

Rome IV Diagnostic Criteria for Functional Anorectal Pain

Check the criteria that apply to the patient. The Rome IV criteria for functional anorectal pain (F2) require all five chronic proctalgia criteria to be met. The puborectalis tenderness finding then differentiates levator ani syndrome (F2a, tenderness present) from unspecified functional anorectal pain (F2b, tenderness absent).

Required criteria (all must be met)

All of the following criteria must be present for a positive diagnosis of chronic proctalgia.

Differentiating criterion (subtype classification)

This finding determines whether the diagnosis is levator ani syndrome (F2a) or unspecified functional anorectal pain (F2b). Select the appropriate finding below.

Tenderness during posterior traction on the puborectalis muscle

Digital rectal examination reveals tenderness during posterior traction on the puborectalis muscle. Presence of tenderness differentiates levator ani syndrome (F2a) from unspecified functional anorectal pain (F2b).

Disclaimer: The Rome IV diagnostic criteria for functional anorectal pain are an educational clinical decision-support tool. They do not replace comprehensive clinical evaluation, appropriate diagnostic workup, or clinical judgment. This tool evaluates chronic proctalgia (levator ani syndrome and unspecified functional anorectal pain) and does not assess proctalgia fugax, which is a separate acute entity. Always perform appropriate evaluation before applying these criteria.

Rome IV Criteria for Functional Anorectal Pain: formula, variables, and clinical context

Overview

Functional anorectal pain is classified as category F2 under the Rome IV criteria for disorders of gut-brain interaction (2016). It encompasses chronic proctalgia, subdivided into levator ani syndrome (F2a) and unspecified functional anorectal pain (F2b), as well as the distinct acute entity of proctalgia fugax (F2c). This calculator evaluates the chronic proctalgia subtypes (F2a and F2b). Chronic proctalgia is thought to be secondary to paradoxical pelvic floor contraction in many patients, and the key differentiating feature between the two subtypes is the presence or absence of tenderness during posterior traction on the puborectalis muscle on digital rectal examination.

Diagnostic criteria for chronic proctalgia

All of the following must be fulfilled:

#	Criterion	Requirement
1	Chronic or recurrent pain	Chronic or recurrent rectal pain or aching localized to the rectum
2	Episode duration	Episodes last 30 minutes or longer (distinguishes chronic proctalgia from proctalgia fugax)
3	Exclusion of organic causes	Other causes of rectal pain have been excluded (ischemia, inflammatory bowel disease, cryptitis, hemorrhoids, anal fissures, tumor)
4	Symptom onset	Symptoms must have begun at least 6 months prior to diagnosis
5	Active symptoms	Criteria must have been fulfilled for the last 3 months

Interpretation: If all five criteria are met, the patient fulfills the Rome IV diagnostic criteria for chronic proctalgia. The subtype is then determined by the puborectalis tenderness finding (see below).

Subtype differentiation

Subtype	Code	Puborectalis tenderness	Key features
Levator ani syndrome	F2a	Present	Tenderness during posterior traction on the puborectalis muscle on digital rectal examination. Responsive to biofeedback therapy in clinical trials.
Unspecified functional anorectal pain	F2b	Absent	Meets all chronic proctalgia criteria but lacks tenderness on puborectalis palpation. Management options are more limited and less well studied.

Proctalgia fugax (F2c): the acute counterpart

Proctalgia fugax is a separate entity under functional anorectal pain, distinguished by its acute, brief episodes. It is not scored by this calculator but is included here for completeness.

Feature	Chronic proctalgia (F2a/F2b)	Proctalgia fugax (F2c)
Episode duration	30 minutes or longer	Seconds to minutes (maximum 30 minutes)
Pain between episodes	May be present	No anorectal pain between episodes
Relation to defecation	Variable	Unrelated to defecation
Treatment evidence	Biofeedback effective for levator ani syndrome	Modest evidence; inhaled salbutamol, topical diltiazem

Rome IV anorectal disorders (category F)

Functional anorectal pain is one of three major categories of anorectal disorders defined by Rome IV:

Category	Disorder	Key features
F1	Fecal incontinence	Recurrent uncontrolled passage of fecal material; no distinction between functional and structural causes
F2	Functional anorectal pain	Includes levator ani syndrome (F2a), unspecified functional anorectal pain (F2b), and proctalgia fugax (F2c)
F3	Functional defecation disorders	Includes inadequate defecatory propulsion and dyssynergic defecation

Epidemiology

Chronic proctalgia affects approximately 6-7% of the general population, though prevalence estimates vary widely depending on the population studied and diagnostic criteria used.
Levator ani syndrome is more common in women than in men. It is most frequently diagnosed in patients aged 30-60 years.
Proctalgia fugax is reported in approximately 8-18% of the population, with many patients experiencing infrequent episodes that do not prompt medical evaluation.
Functional anorectal pain is substantially underdiagnosed. Many patients do not volunteer symptoms unless specifically asked, and the condition may be misattributed to hemorrhoids or other structural causes.

Pathophysiology

The pathophysiology of functional anorectal pain is incompletely understood, but several mechanisms have been implicated:

Pelvic floor muscle spasm: Chronic contraction or spasm of the levator ani muscles (particularly the puborectalis and pubococcygeus) is the most widely cited mechanism for levator ani syndrome. This may represent a form of tension myalgia.
Dyssynergic defecation overlap: Many patients with levator ani syndrome have coexisting dyssynergic defecation, suggesting shared neuromuscular pathology involving inappropriate pelvic floor contraction.
Visceral hypersensitivity: Altered central and peripheral pain processing may lower the threshold for perception of anorectal sensation, similar to mechanisms described in other functional GI disorders.
Pudendal neuropathy: Injury or entrapment of the pudendal nerve can produce chronic perineal and anorectal pain that mimics or overlaps with functional anorectal pain syndromes.
Psychosocial factors: Anxiety, depression, catastrophizing, and history of physical or sexual abuse are reported at higher rates in patients with chronic proctalgia compared to healthy controls.

Diagnostic evaluation

A systematic evaluation is recommended to characterize the pain, exclude organic causes, and guide treatment:

Detailed history (onset, duration, frequency, relation to defecation, aggravating/relieving factors)

Digital rectal examination with posterior traction on the puborectalis muscle

Assessment for puborectalis/levator ani tenderness

Exclusion of structural causes (hemorrhoids, fissures, abscess, fistula, tumor)

Anorectal manometry (resting and squeeze pressures, rectal sensation, balloon expulsion)

Endoanal or endorectal ultrasonography (if structural lesion suspected)

Defecography or MR defecography (if dyssynergia suspected)

Colonoscopy or sigmoidoscopy (if mucosal disease or malignancy suspected)

Psychosocial assessment (anxiety, depression, abuse history)

Pudendal nerve terminal motor latency (if pudendal neuropathy suspected)

Management considerations

Approach	Details
Biofeedback therapy (levator ani syndrome)	The treatment with the strongest evidence base for levator ani syndrome. Biofeedback targets defecatory dynamics and pelvic floor relaxation. Randomized controlled trials show improvement in over 85-90% of patients in the short term. It is recommended as first-line therapy.
Electrogalvanic stimulation	Intra-anal or intra-rectal electrical stimulation aimed at reducing levator spasm. Some studies report symptom improvement, particularly in patients with levator ani syndrome, though evidence is less robust than for biofeedback.
Digital massage of the levator ani	Repeated digital massage of the levator ani muscle through the rectum. May provide temporary relief for some patients with levator ani syndrome.
Pharmacotherapy	Muscle relaxants (e.g., methocarbamol, diazepam), topical nitroglycerin or diltiazem, and tricyclic antidepressants or gabapentinoids for neuropathic pain components. Evidence for specific pharmacological agents is limited.
Sitz baths	Warm sitz baths may provide symptomatic relief by promoting pelvic floor relaxation. Often used as an adjunctive measure.
Botulinum toxin injection	Injection of botulinum toxin into the levator ani or puborectalis muscle has been studied in small trials. Results are mixed, and this approach is generally reserved for refractory cases.
Psychological therapies	Cognitive behavioral therapy, relaxation training, and hypnotherapy may be beneficial, particularly in patients with significant psychosocial comorbidity. A multidisciplinary approach is often optimal for refractory cases.

Limitations

Subjective physical exam finding: The differentiating feature between levator ani syndrome and unspecified functional anorectal pain (tenderness on puborectalis traction) depends on clinician technique and patient reporting, introducing inter-observer variability.
Symptom-based diagnosis: The criteria rely on patient-reported symptoms, which may be affected by recall bias, pain catastrophizing, and reluctance to discuss anorectal symptoms.
Overlap with other conditions: Functional anorectal pain frequently overlaps with dyssynergic defecation, irritable bowel syndrome, and chronic pelvic pain syndromes. The criteria do not fully address these comorbidities.
Proctalgia fugax not included: This calculator evaluates chronic proctalgia only. Proctalgia fugax (F2c) has separate diagnostic criteria involving brief episodes lasting seconds to minutes.
Duration requirement may delay diagnosis: The 6-month onset and 3-month active symptom requirements mean that newly symptomatic patients cannot be formally diagnosed, even if evaluation and treatment may be warranted earlier.
Limited treatment evidence for F2b: While biofeedback has strong evidence for levator ani syndrome, treatment options for unspecified functional anorectal pain are less well studied and less effective.

Key references

Rao SS, Bharucha AE, Chiarioni G, Felt-Bersma R, Knowles C, Malcolm A, et al. Anorectal disorders. Gastroenterology. 2016;150(6):1430-1442.
Simren M, Palsson OS, Whitehead WE. Update on Rome IV criteria for colorectal disorders: implications for clinical practice. Curr Gastroenterol Rep. 2017;19(4):15.
Bharucha AE, Wald A, Enck P, Rao S. Functional anorectal disorders. Gastroenterology. 2006;130(5):1510-1518.
Chiarioni G, Nardo A, Vantini I, Romito A, Whitehead WE. Biofeedback is superior to electrogalvanic stimulation and massage for treatment of levator ani syndrome. Gastroenterology. 2010;138(4):1321-1329.
Rao SS, Seaton K, Miller MJ, et al. Psychological profiles and quality of life differ between patients with dyssynergia and those with slow transit constipation. J Psychosom Res. 2007;63(4):441-449.

Practice caveats

The digital rectal examination with posterior traction on the puborectalis is the critical differentiating maneuver. It should be performed gently but with sufficient traction to elicit the tenderness finding.
Always exclude structural causes of anorectal pain (particularly anal fissure, perianal abscess, and thrombosed hemorrhoids) before diagnosing a functional disorder. A careful external and internal examination is essential.
Patients with levator ani syndrome should be offered biofeedback therapy as first-line treatment. This is the only approach with demonstrated efficacy in randomized trials for this specific condition.
Consider pudendal neuralgia in the differential for patients with chronic perineal or anorectal pain, particularly when pain follows the pudendal nerve distribution and is worse with sitting.

Background and scope

Functional anorectal pain describes chronic rectal or anal pain in the absence of a sufficient structural or inflammatory explanation after appropriate evaluation. Under Rome IV, these disorders sit within the anorectal category (F2). This framework is intended to support a symptom-based diagnosis when the clinical picture fits defined temporal and qualitative rules and when alternative causes have been thoughtfully excluded.

Clinicians often encounter patients with deep rectal aching, pressure, or pain that is difficult to localize and may fluctuate over time. Rome criteria do not replace history, examination, or targeted testing; they organize findings so that care pathways (for example pelvic floor–directed therapy) can align with a recognized functional diagnosis.

How Rome IV subdivides anorectal pain

Rome IV separates entities by symptom pattern and, for chronic proctalgia, by a specific physical examination finding:

F2a Levator ani syndrome: chronic proctalgia criteria are met, and tenderness is elicited during posterior traction on the puborectalis muscle on digital examination.
F2b Unspecified functional anorectal pain: chronic proctalgia criteria are met, but tenderness with that maneuver is absent.
F2c Proctalgia fugax: a distinct syndrome of brief, severe anorectal pain episodes. It is not classified using the same chronic proctalgia checklist as F2a and F2b. Brief paroxysmal pain that does not meet the duration pattern below should prompt consideration of proctalgia fugax or other causes rather than forcing a chronic proctalgia label.

Chronic proctalgia: the shared Rome IV core

Both levator ani syndrome and unspecified functional anorectal pain require the same five prerequisite criteria. All must be satisfied before subtype assignment. Think of this as a gate: if any prerequisite fails, the patient does not meet Rome IV functional anorectal pain (chronic proctalgia) under this scheme, and evaluation should continue for other explanations or evolving presentations.

1. Chronic or recurrent rectal pain or aching

The symptom should be experienced in or referred to the rectal region and may be described as pressure, aching, heaviness, or pain. Chronicity or recurrence is essential. The complaint is not required to be constant; episodic symptoms are compatible if they recur in a pattern consistent with a persistent clinical problem rather than a single self-limited event.

2. Episodes last thirty minutes or longer

Duration distinguishes chronic proctalgia from proctalgia fugax, in which attacks are typically very short (often seconds to a few minutes) and, in Rome IV, are capped in conceptual contrast to the prolonged episodes required here. If the patient’s painful spells reliably remain under thirty minutes, chronic proctalgia by Rome IV is generally not the right fit, and alternative diagnoses (including fugax or other sources of brief pain) deserve emphasis.

3. Other causes of rectal pain have been excluded

This criterion anchors functional labeling on a reasonable search for organic and local pathology. The exact workup should be individualized, but the intent is to rule out or treat, when present, conditions such as:

Anal fissure, thrombosed hemorrhoids, abscess, fistula, or significant proctitis
Inflammatory bowel disease involving the rectum
Ischemic or vascular mechanisms when suggested by history or risk
Structural lesions including neoplasm when alarm features or examination findings warrant investigation
Other identifiable sources of anorectal or pelvic pain (for example some infections or post-surgical complications) when clinically relevant

“Excluded” in practice means the clinician has integrated history, digital examination, and appropriate ancillary tests for the scenario, not that every possible test has been performed regardless of pretest probability.

4. Symptom onset at least six months before diagnosis

Rome IV uses a six-month onset window to separate longstanding functional syndromes from newer symptoms that may still declare an alternative diagnosis. Early in the course, watchful follow-up, symptom diaries, and repeat examination may be more appropriate than applying a definitive functional label.

5. Active symptoms during the last three months

The disorder must be currently active: within the three months preceding assessment, the patient should have experienced the qualifying pain pattern. This prevents labeling remote historical episodes as a present Rome IV diagnosis when the patient is actually asymptomatic.

Subtype differentiation: puborectalis tenderness

Once all five prerequisites are met, Rome IV assigns F2a versus F2b using a standardized examination concept: tenderness during posterior traction on the puborectalis muscle on digital rectal examination. The maneuver isolates feedback from the puborectalis portion of the levator complex; tenderness with that traction supports levator ani syndrome (F2a), while absence of tenderness supports unspecified functional anorectal pain (F2b).

Examination technique and interpretation require experience. Patient anxiety, guarding, concurrent anal pathology, or prior surgery can confound palpation. When the examination is equivocal or not performed, the calculator cannot substitute for clinical judgment; documenting uncertainty and repeating the exam in a controlled setting may be necessary.

How this maps to the CalcMD checklist

The tool mirrors the Rome IV logic:

It verifies the five chronic proctalgia prerequisites. If any are not met, the output reflects that Rome IV functional anorectal pain (chronic proctalgia) is not diagnosed by these criteria.
If all five are met, it uses your entry for puborectalis tenderness to distinguish F2a from F2b. If tenderness is not assessed, interpret results cautiously in real practice.

Rome labels are aids for communication, research, and structured management (for example biofeedback-oriented approaches are often discussed for levator-related pain). They are not a substitute for individualized assessment, shared decision-making, or follow-up when symptoms change.

Important limitations

This page and calculator are for education and organization of criteria, not autonomous diagnosis or treatment.
Rome IV does not specify every test for every patient; exclusion of organic disease remains a clinical determination.
Coexisting conditions (irritable bowel syndrome, dyssynergic defecation, pelvic floor hypertonicity without pain, centralized pain sensitization) may overlap; comorbidity does not invalidate careful criterion-based labeling when the pain syndrome itself fits F2.
Proctalgia fugax and other acute or brief pain syndromes should not be forced into the chronic proctalgia pathway.